HealthCor Management
Latest statistics and disclosures from HealthCor Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are BMRN, DXCM, CYTK, ACRV, HYPR, and represent 81.13% of HealthCor Management's stock portfolio.
- Added to shares of these 8 stocks: DXCM (+$7.7M), ACRV, CNMD, ISRG, PEN, Rain Therapeutics, HYPR, Silk Road Medical Inc Common.
- Started 6 new stock positions in ACRV, Rain Therapeutics, ISRG, CNMD, PEN, Silk Road Medical Inc Common.
- Reduced shares in these 10 stocks: , , BMRN (-$41M), BSX (-$37M), LLY (-$33M), , , DHR (-$30M), , TMO (-$26M).
- Sold out of its positions in ABT, ABBV, A, COR, AMGN, ELV, BDX, BIIB, Bluebird Bio, BSX.
- HealthCor Management was a net seller of stock by $-719M.
- HealthCor Management has $109M in assets under management (AUM), dropping by -86.35%.
- Central Index Key (CIK): 0001343781
Tip: Access up to 7 years of quarterly data
Positions held by HealthCor Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for HealthCor Management
HealthCor Management holds 22 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| BioMarin Pharmaceutical (BMRN) | 34.9 | $38M | -51% | 368k | 103.49 |
|
| Dex (DXCM) | 33.4 | $36M | +26% | 321k | 113.24 |
|
| Cytokinetics Com New (CYTK) | 6.9 | $7.5M | -62% | 164k | 45.82 |
|
| Acrivon Therapeutics Common Stock (ACRV) | 3.0 | $3.3M | NEW | 284k | 11.52 |
|
| Hyperfine Com Cl A (HYPR) | 3.0 | $3.3M | +41% | 3.9M | 0.84 |
|
| Alkermes SHS (ALKS) | 2.6 | $2.9M | -63% | 110k | 26.13 |
|
| CONMED Corporation (CNMD) | 2.2 | $2.4M | NEW | 28k | 88.64 |
|
| Neurocrine Biosciences (NBIX) | 2.2 | $2.4M | -7% | 20k | 119.44 |
|
| Syndax Pharmaceuticals (SNDX) | 1.6 | $1.8M | -91% | 70k | 25.45 |
|
| Chinook Therapeutics | 1.4 | $1.6M | -77% | 60k | 26.20 |
|
| Intuitive Surgical Com New (ISRG) | 1.4 | $1.5M | NEW | 5.8k | 265.35 |
|
| Blueprint Medicines (BPMC) | 1.2 | $1.3M | -71% | 30k | 43.81 |
|
| Geron Corporation (GERN) | 1.1 | $1.2M | -73% | 500k | 2.42 |
|
| Penumbra (PEN) | 1.0 | $1.1M | NEW | 5.0k | 222.46 |
|
| Rocket Pharmaceuticals (RCKT) | 0.9 | $979k | -88% | 50k | 19.57 |
|
| Rain Therapeutics | 0.9 | $960k | NEW | 120k | 8.00 |
|
| Inspire Med Sys (INSP) | 0.8 | $882k | -90% | 3.5k | 251.88 |
|
| Silk Road Medical Inc Common | 0.7 | $793k | NEW | 15k | 52.85 |
|
| ImmunoGen | 0.7 | $744k | -88% | 150k | 4.96 |
|
| Eqrx *w Exp 12/17/202 | 0.0 | $9.5k | 35k | 0.27 |
|
|
| Eucrates Biomedical Acqu Cor *w Exp 10/23/202 | 0.0 | $4.3k | 78k | 0.06 |
|
|
| Medicus Sciences Acquisition *w Exp 02/12/202 | 0.0 | $2.7k | 30k | 0.09 |
|
Past Filings by HealthCor Management
SEC 13F filings are viewable for HealthCor Management going back to 2010
- HealthCor Management 2022 Q4 filed Feb. 15, 2023
- HealthCor Management 2022 Q3 filed Nov. 14, 2022
- HealthCor Management 2022 Q2 filed Aug. 15, 2022
- HealthCor Management 2022 Q1 filed May 16, 2022
- HealthCor Management 2021 Q4 filed Feb. 14, 2022
- HealthCor Management 2021 Q3 filed Nov. 15, 2021
- HealthCor Management 2021 Q2 filed Aug. 16, 2021
- HealthCor Management 2021 Q1 filed May 17, 2021
- HealthCor Management 2020 Q4 filed Feb. 16, 2021
- HealthCor Management 2020 Q3 filed Nov. 16, 2020
- HealthCor Management 2020 Q2 filed Aug. 14, 2020
- HealthCor Management 2020 Q1 filed May 15, 2020
- HealthCor Management 2019 Q4 filed Feb. 14, 2020
- HealthCor Management 2019 Q3 filed Nov. 14, 2019
- HealthCor Management 2019 Q2 filed Aug. 14, 2019
- HealthCor Management 2019 Q1 filed May 15, 2019